President’s Corner: The ACR Is on Your Side

This year, the ACR Executive Committee met with FDA Commissioner Marty Makary, MD, MPH, at the Department of Health & Human Services headquarters on May 6 and with CMS Deputy Administrator Christoper Klomp on May 20.

Want to Know More?

The ACR has communication channels that allow members to remain up to date with the latest news from our advocacy team:

• ACR@Work—The ACR publishes a bimonthly e-newsletter for members with the latest news and activities related to advocacy and policy updates, practice management, insurance issues and more;
• The ACR advocacy website offers members up-to-date news on what’s going on in Washington, D.C., and the ACR’s ongoing efforts to promote pro-rheumatology policies;
• Social media is another way to keep informed on ACR advocacy efforts. Be sure to follow the ACR on Facebook, X, Instagram and LinkedIn. For advocacy specific updates, follow @ ACRheumDC on X.

You can also schedule time to join the ACR’s advocacy team to learn more about our team’s efforts, ask questions about ACR advocacy and find out how you can get involved from home. You will have access to our Congressional, regulatory, state, and private payer advocacy staff, so any concern you have will find the right ears. Contact the ACR advocacy team at [email protected].

What Can You Do?

The ACR’s legislative action center is your destination to advocate for the needs and concerns of rheumatology providers, professionals and patients.

Through the action center, rheumatologists and rheumatology professionals are empowered to speak directly to their legislators on public policy matters that affect the rheumatology profession. It only takes a couple of minutes to send customized messages to your lawmakers through links provided by the ACR.

Your voice as an advocate is essential. Join us to create positive change for rheumatology professionals and patients nationwide.

Carol A. Langford, MD, MHS, is the director of the Center for Vasculitis Care and Research in the Department of Rheumatic and Immunologic Diseases at Cleveland Clinic, where she is professor of medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, and holds the Harold C. Schott endowed chair in rheumatic and immunologic diseases.